Drug Delivery Devices - LATAM
LATAM- Revenue in the Drug Delivery Devices market market in LATAM is projected to reach US$1.75bn in 2024.
- Revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 5.68%, leading to a market volume of US$2.31bn by 2029.
- In a global context, the majority of revenue will be generated the United States, which is expected to reach US$15.01bn in 2024.
- In LATAM, the demand for innovative drug delivery devices is surging, driven by an increasing focus on chronic disease management and patient-centric healthcare solutions.
Definition:
The Drug Delivery Devices market encompasses medical devices and systems designed for the targeted delivery and controlled release of pharmaceutical substances into the body. This market includes a wide range of devices such as inhalers, transdermal patches, infusion pumps, prefilled syringes, and drug-eluting stents. It is important to note that the market does not include the pharmaceutical products themselves but focuses on the technologies and devices used to administer these drugs effectively.
Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
Key players in the market include Medtronic, Beckton, Dickinson & Co., and Janssen Pharmaceuticals. Further information on the key players can be found in the Market Shares boxes.
In-Scope
- Drug delivery systems and devices (e.g., inhalers, transdermal patches, infusion pumps, prefilled syringes)
- Implantable drug delivery devices (e.g., drug-eluting stents, implantable infusion pumps)
- Needle-free drug delivery technologies
Out-Of-Scope
- Pharmaceutical drugs
- Supplements and nutraceuticals
- Manual administration methods (e.g., standard syringes, oral tablets without specialized delivery systems)
